Free radicals and oxidative stress challenge dialysis patients: Effects of two different membranes

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Biasioli, Stefano ^a   Schiavon, Renzo ^a   Petrosino, Luigi ^a   Cavallini, Luigi ^a   Zambello, Alberto ^a   De Fanti, Emanuela ^a   Giavarina, Davide ^a  

^a Legnago Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DIALYSIS MEMBRANES; DISEASES; ENZYMES; FREE RADICALS; OXIDATION; PATIENT TREATMENT; SPECTROPHOTOMETRY;

CATALASE; END STAGE RENAL DISEASES; ERYTHROCYTE; HEMODIALYSIS; OXIDATIVE STRESS; PLASMA LIPID PEROXIDATION; REACTIVE OXYGEN SPECIES;

DIALYSIS;

BICARBONATE; CATALASE; FREE RADICAL; GLUTATHIONE;

CONFERENCE PAPER; DIALYSIS; ENZYME ACTIVITY; KIDNEY FAILURE; LIPID PEROXIDATION; MEMBRANE PERMEABILITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ADULT; CATALASE; CELLULOSE; ERYTHROCYTES; FEMALE; FREE RADICALS; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; LIPID PEROXIDATION; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; SUPEROXIDE DISMUTASE;

EID: 0031238501     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Rosemund A, Binswanger U, Straub W: Oxidative injury to erythrocytes, cell rigidity and splenic haemolysis in haemodialyzed uremic patients. Ann Intern Med 82: 460-465, 1975.
2. Kikuchi Y, KoyamaT, Koyama Y, et al: Red blood cell deformability in renal failure. Nephron 30: 8-14, 1982.
3. Lindsay RM, Moorthy AV, Koens F, Linton AL: Platelet function in dialyzed patients with chronic renal failure. Clin Nephrol 4: 52-57, 1975.
4. Heyningen R, Harding JJ: Do aspirin-like analgesics protect against cataract? Lancet 1: 1111-1113, 1986.
5. Gutteridge J: Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin Chem 41: 1819-1828, 1995.
6. Roos D: The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin Wochenschr 69: 975-980, 1991.
7. Halliwell B: Current status review: Free radicals, reactive oxygen species and human disease. A critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 70: 737-757, 1989.
8. Frei B, Stocker R, Ames BN: Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85: 9748-9752, 1982.
9. Kuroda M, Asaka S, Tofuku Y, Takeda R: Serum antioxidant activity in uraemic patients. Nephron 41: 293-298, 1986.
10. Ono K: Effects of large dose vitamin E supplementation on anaemia in haemodialysis patients. Nephron 40: 440-445, 1985.
11. Taccone-Gallucci M, Giardini O, Lubrano R, et al: Red blood cell peroxidation in predialysis renal failure. Clin Nephrol 27: 238-241, 1987.
12. Taccone-Gallucci M, Lubrano R, Bandino D, et al: Discrepancies between serum and erythrocyte concentrations of vitamin E in haemodialysis patients. Role of HDL-bound fraction of vitamin E. Artif Organs 12: 379-381, 1988.
13. Yawata Y, Jacob H: Abnormal red cell metabolism in patients with chronic anemia: Nature of the defect and its persistence despite adequate haemodialysis. Blood 45: 231-239, 1975.
14. Himmelfarb J, Lazarus M, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 3: 271-276, 1991.
15. Luciak M, Trznadel K: Free oxygen species metabolism during haemodialysis with different membranes. Nephrol Dial Transplant Suppl 3: 66-70, 1991.
16. Miguel A, Linares M, Perez A, et al: Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron 50: 64-65, 1988.
17. Richard MJ, Arnaud J, Jurkovilz C, et al: Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57: 10-15, 1991.
18. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie JB: Thiobarbituric acid reactive material in uraemic blood. Nephron 29: 40-43, 1981
19. Dasgupta A, Hussain S, Ahmad S: Increased lipid peroxidation in patients on maintenance haemodialysis. Nephron 60: 56-59, 1992.
20. Taylor JE, Scou N, Bridges A, Henderson IS, Stewart WK, Belch JJF: Lipid peroxidation in continuous ambulatory dialysis patients. Perit Dial Int 12: 252-256, 1992.
21. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of haemodialysis in lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 41: 1229-1232, 1992.
22. Giardini O, Taccone-Gallucci M, Lubrano R, et al: Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 36: 235-237, 1984.
23. Maher ER, Wickens DG, Griffin JFA, Kyle P, Curtis JR, Dormandy TL: Neutropenia and plasma free radical reaction products during haemodialysis. Nephrol Dial Transplant 3: 277-283, 1988.
24. McGrath LT, Douglas AF, McClean E, Brown J, Doherty C, Jonhston G, Archbold G: Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular HD. Clin Chim Acta 235: 179-188, 1995.
25. Girelli D, Azzini M, Olivieri O, et al: Red blood cells and platelet membrane fatty acids in nondialyzed and dialyzed uremics. Clin Chim Acta 211: 155-166, 1992.
26. Chauhan DP, Gupta PH, Nampoothiri MRN, Singhal PC, Chugh KS, Nair CR: Determination of erythrocyte superoxidedismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uraemia. Clin Chim Acta 123: 153-159, 1982.
27. Tzrnadel K, Pawlicki L, Kedziora J, Luciak M, Blaszozyk J, Buczynski A: Superoxide anion generation, erythrocytes superoxidedismutase activity and lipid peroxidation during haemoperfusion and haemodialysis in chronic uremic patients. Free Radical Biology Medicine 6: 393-397, 1989.
28. Delmas-Beauviex MC, Combe C, Penchant E, Carboneau MA: Evaluation of RCB lipoperoxidation in HD patients during EPO therapy supplemented or not with iron. Nephron 69: 404-410, 1995.
29. Taccone-Gallucci M, Lubrano R, Del Principe D, et al: Platelet lipid peroxidation in haemodialysis patients: Effects of vitamin E supplementation. Nephrol Dial Transplant 4: 975-978, 1989.
30. Vanella A, Geromia E, Pinturo R: Superoxide dismutase activity and reduced glutathione content in erythrocytes of uremic patients on chronic dialysis. Acta Haematol 70: 312-315, 1983.
31. Giardini O, Taccone-Gallucci M, Lubrano R: Effects of alphatocopherol administration on red blood cell membrane lipid peroxidation in haemodialysis patients. Clin Nephrol 21: 174-177, 1984.
32. Cornelis R, Mees L, Ringoir S: Serum and red blood cell Zn, Se, Cs and Rb in dialysis patients. Mineral Electrolyte Metab 2: 85-93, 1979.
33. Blum J, Fridovich L: Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 240: 500-508, 1985.
34. Biasioli S, Schiavon R, De Fanti E, Cavalcanti G, Giavarina D: Tha role of erythrocites in the deperoxidative processes in people on HD. ASAIO J 42: 890-894, 1996.
35. Westhuyzen J, Adams CE, Fleming SJ: Evidence for oxidative styress during in vitro dialysis. Nephron 70: 49-54, 1995.
36. Sanaka T, Higuchi C, Shinobe T, Nishimura H, Omata M: Lipid peroxidation as an indicator of biocompatibility in HD. Nephrol Dial Transplant 10: 34-38, 1995.
37. Gunzler WA, Kremers H, Flohe L: An improved coupled test procedure for glutathione peroxidase in blood. Z Klin Chem Klin Biochem 12: 444-448, 1974.
38. Beutler E: Red cell metabolism: A manual of biochemical methods, 2nd ed., New York, Grune and Stratton, 1975, p. 71-73.
39. Smilh CV, Anderson RE: Methods for determination of lipid peroxidation in biological samples. Free Radical Biology Medicine 3: 341-344, 1937.
40. Gey KF: The anti-oxidant hypothesis. Bibl Nutr Dieta 37: 53-91, 1986.
41. El-Rashidy FH, Al-Turk WA, Slohs SJ: Glutathione, glutathione reductase and glutathione S-transferase activities in erythrocytes and lymphocytes in chronic renal disease. Res Commun Chem Pathol Pharmacol 44: 423-430, 1984.
42. Paul JP, Sall N, Soni T, et al: Lipid peroxidation abnormalities in HD patients. Nephron 64: 106-109, 1993.
43. Yim MB, Boon Chock P, Stadtman ER: Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J Biol Chem 268(6): 4099-4105, 1993.
44. Durak I, Akyiol Ö, Basesme E, Canbolat O, Kavutcu M: Reduced erythrocyte defense mechanism against free radical toxicity in patients with CRF. Nephron 66: 76-80, 1994.
45. Turi S, Nemeth I, Varga I, Matcoviks B, Dobos E: Erythrocyte defense mechanism against free oxygen radicals in HD children. Pediatr Nephrol 5: 179-83, 1991.
46. Seth RK, Satni AS, Aggarwal SK: Glutathione peroxidase and reduced glutathione content in erythrocytes of patients with CRF. Scand J Haematol 35: 201-4, 1985.
47. Asayama K, Shiki Y, Ito H, Hasegawa O, Miyao A: Antioxidant enzymes and liperoxide in blood in uremic children and adolescent. Free Radical Biology Medicine 9: 105-9, 1990.
48. Melissinos KG, Delidou AZ, Varsou AG, Begietti SS, Drivas GJ: Serum and erythrocyte glutathione reductase activity in chronic renal failure. Nephron 28: 76-79, 1981.
49. Mimic-Oka J, Djukanovic LJ, Markovic B: Erythrocyte and plasma glutathione levels in patients with chronic renal insufficiency. Biochem Med Metab Biol 39: 48-54, 1988.
50. Mimic-Oka J, Simic T, Djukanovic LJ, Stefanovski J, Ramic Z: Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency. Amino Acids 2: 215-224, 1992.
51. Mimic-Oka J, Simic T, Ekmescic V, Dragicevic P: Erythrocyte GPx and SOD activities in different stages of CRF. Clin Nephrol 44: 44-4S, 1995.
52. Jackson P, Loughrey CM, Lightbody J, McNamec P, Young L: Effects of HD on total antioxidant capacity and serum antioxidants in patients with CRF. Clin Chem 41: 1135-1138, 1995.
53. Amstad P, Moret R, Cerutti P: Glutathione peroxidase compensates for the hypersensitivity of cuprophan, Zn superoxide dismutase over producers to oxidant stress. J Biol Chem 269: 1606-1609, 1994.
54. Sheriff DS: Erythrocyte glutathione concentration as a measure of oxidant stress in patients undergoing dapsone therapy. Ann Clin Biochem 26: 199-200, 1989.
55. Pascucci M, Canestrari F, Galli F, Biagiarelli B, Galiotta P: Stress eritrocitario nei trattamenti dialitici extracorporei. Livelli enzimatici, stato energetico e redox. Giorn It Nefrol 9: 183-88, 1992.
56. Hashimoto H, Mio T, Sumino K: Lipid abnormalities of erythrocyte membranes in HD patients with CRF. Clin Chim Acta 252: 137-145, 1996.
57. Witko SV, Friedlander M, Capeillere C, Nguyen K, Zingraff J: Advanced oxidation protein product as a novel marker of oxidative stress in uremia. Kidney Int 49(5): 1304-1313, 1996.
58. Odetti P, Garibaldi S, Gurreri G, Aragno I, Dapino D: Protein oxidation in HD and kidney transplantation. Metabolism 45(11): 1319-1322, 1996.
59. Lin T, Chen JG, Liaw JM, Juang JG: Trace elements and lipid peroxidation in uremic patients on HD. Biol Trace Elem Res 51: 277-283, 1996.
60. Banni S, Lucchi L, Baraldi A, et al: No direct evidence of increased lipid peroxidation in HD patients. Nephron 7: 177-183, 1996.
61. Nagase S, Aoyagi K, Hirayama A, Gotoh M: Decreased serum antioxidant activity of HD patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation. Nephron 74: 1555-560, 1996.
62. Eisselt J, Racek J, Holecek V, Krejcova I: Antioxidant and malondialdehyde during HD with CDA and PS membranes. Cas Lek Cesk 135: 691-694, 1996.